• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Epidemiology of interdialytic ambulatory hypertension and the role of volume excess.透析间动态高血压的流行病学和容量过多的作用。
Am J Nephrol. 2011;34(4):381-90. doi: 10.1159/000331067. Epub 2011 Sep 2.
2
Inferior vena cava diameter and left atrial diameter measure volume but not dry weight.下腔静脉直径和左心房直径可测量容量而非干重。
Clin J Am Soc Nephrol. 2011 May;6(5):1066-72. doi: 10.2215/CJN.09321010. Epub 2011 Feb 17.
3
Aortic Stiffness, Ambulatory Blood Pressure, and Predictors of Response to Antihypertensive Therapy in Hemodialysis.血液透析患者的主动脉僵硬度、动态血压与降压治疗反应的预测因素。
Am J Kidney Dis. 2015 Aug;66(2):305-12. doi: 10.1053/j.ajkd.2015.01.018. Epub 2015 Mar 25.
4
Intensive Hemodialysis, Blood Pressure, and Antihypertensive Medication Use.强化血液透析、血压和降压药物的使用。
Am J Kidney Dis. 2016 Nov;68(5S1):S15-S23. doi: 10.1053/j.ajkd.2016.05.026.
5
Profile of interdialytic blood pressure in hemodialysis patients.血液透析患者透析间期血压概况
Am J Nephrol. 2003 Mar-Apr;23(2):96-105. doi: 10.1159/000068038.
6
Hemodialysis-associated hypertension: pathophysiology and therapy.血液透析相关高血压:病理生理学与治疗
Am J Kidney Dis. 2002 Feb;39(2):227-44. doi: 10.1053/ajkd.2002.30542.
7
Chronobiology of arterial hypertension in hemodialysis patients: implications for home blood pressure monitoring.血液透析患者动脉高血压的时间生物学:对家庭血压监测的影响
Am J Kidney Dis. 2009 Oct;54(4):693-701. doi: 10.1053/j.ajkd.2009.03.018. Epub 2009 Jun 10.
8
Blood pressure measurements and left ventricular mass index in hemodialysis patients.血液透析患者的血压测量和左心室质量指数。
Artif Organs. 2012 Jun;36(6):517-24. doi: 10.1111/j.1525-1594.2011.01401.x. Epub 2012 Feb 6.
9
Prevalence and control of hypertension among patients on haemodialysis.血液透析患者高血压的患病率和控制情况。
Eur J Clin Invest. 2020 Oct;50(10):e13292. doi: 10.1111/eci.13292. Epub 2020 Jun 29.
10
Interdialytic blood pressure obtained by ambulatory blood pressure measurement and left ventricular structure in hypertensive hemodialysis patients.通过动态血压测量获得的高血压血液透析患者透析间期血压与左心室结构
Hemodial Int. 2008 Jul;12(3):322-7. doi: 10.1111/j.1542-4758.2008.00275.x.

引用本文的文献

1
Assessment of Hypertension in Hemodialysis Patients with the Concomitant Use of Peridialytic and Interdialytic Ambulatory Blood Pressure Measurements.在血液透析患者中同时使用透析期间和透析间期动态血压测量评估高血压
Life (Basel). 2025 Aug 14;15(8):1290. doi: 10.3390/life15081290.
2
Influence of Exercise on Oxygen Consumption, Pulmonary Ventilation, and Blood Gas Analyses in Individuals with Chronic Diseases.运动对慢性病患者氧耗量、肺通气及血气分析的影响
Life (Basel). 2025 Aug 7;15(8):1255. doi: 10.3390/life15081255.
3
Should We Use Renin-Angiotensin-System Inhibitors As a First-Line Therapy for the Management of Hypertension in Patients Receiving Hemodialysis?我们是否应该将肾素-血管紧张素系统抑制剂作为接受血液透析患者高血压管理的一线治疗方法?
Am J Cardiovasc Drugs. 2025 Aug 7. doi: 10.1007/s40256-025-00756-7.
4
I Brazilian guideline on hypertension in dialysis of the Brazilian Society of Nephrology.我是巴西肾脏病学会巴西透析高血压指南。 (此译文逻辑较怪,原英文表述不太完整准确,可能正确表述是:我是巴西肾脏病学会发布的巴西透析高血压指南 ) 按现有英文直接翻译就是这样,供你参考。
J Bras Nefrol. 2025 Jan-Mar;47(1):e20240033. doi: 10.1590/2175-8239-JBN-2024-0033en.
5
Pharmacological management of hypertension and outcome among patients on hemodialysis at Muhimbili National Hospital, Tanzania: a cross-sectional study.坦桑尼亚穆希比利国家医院血液透析患者的高血压药物治疗与结局:一项横断面研究。
Pan Afr Med J. 2023 Oct 24;46:67. doi: 10.11604/pamj.2023.46.67.39778. eCollection 2023.
6
Renal Denervation in End-Stage Renal Disease: Current Evidence and Perspectives.终末期肾病中的肾去神经支配:当前证据与展望
High Blood Press Cardiovasc Prev. 2024 Jan;31(1):7-13. doi: 10.1007/s40292-023-00621-1. Epub 2024 Jan 25.
7
Resistant Hypertension in Dialysis: Epidemiology, Diagnosis, and Management.透析患者的难治性高血压:流行病学、诊断与管理
J Am Soc Nephrol. 2024 Apr 1;35(4):505-514. doi: 10.1681/ASN.0000000000000315. Epub 2024 Jan 16.
8
Which blood pressure metrics should be used in patients on dialysis?透析患者应使用哪些血压指标?
Kidney Res Clin Pract. 2024 Mar;43(2):133-142. doi: 10.23876/j.krcp.23.126. Epub 2023 Nov 14.
9
Pathophysiological concepts and screening of cardiovascular disease in dialysis patients.透析患者心血管疾病的病理生理概念与筛查
Front Nephrol. 2023 Sep 29;3:1198560. doi: 10.3389/fneph.2023.1198560. eCollection 2023.
10
Diagnosis and treatment of hypertension in dialysis patients: a systematic review.透析患者高血压的诊断与治疗:一项系统评价
Clin Hypertens. 2023 Sep 1;29(1):24. doi: 10.1186/s40885-023-00240-x.

本文引用的文献

1
Inferior vena cava diameter and left atrial diameter measure volume but not dry weight.下腔静脉直径和左心房直径可测量容量而非干重。
Clin J Am Soc Nephrol. 2011 May;6(5):1066-72. doi: 10.2215/CJN.09321010. Epub 2011 Feb 17.
2
Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial.选择性维生素 D 受体激活剂帕立骨化醇降低 2 型糖尿病患者蛋白尿(VITAL 研究):一项随机对照试验。
Lancet. 2010 Nov 6;376(9752):1543-51. doi: 10.1016/S0140-6736(10)61032-X.
3
Dry-weight: a concept revisited in an effort to avoid medication-directed approaches for blood pressure control in hemodialysis patients.干体重:在努力避免药物指导的血液透析患者血压控制方法的过程中重新审视的一个概念。
Clin J Am Soc Nephrol. 2010 Jul;5(7):1255-60. doi: 10.2215/CJN.01760210. Epub 2010 May 27.
4
Blood pressure and mortality among hemodialysis patients.血液透析患者的血压与死亡率。
Hypertension. 2010 Mar;55(3):762-8. doi: 10.1161/HYPERTENSIONAHA.109.144899. Epub 2010 Jan 18.
5
Arterial hypertension induced by erythropoietin and erythropoiesis-stimulating agents (ESA).促红细胞生成素和促红细胞生成刺激剂(ESA)所致的动脉高血压。
Clin J Am Soc Nephrol. 2009 Feb;4(2):470-80. doi: 10.2215/CJN.05040908.
6
Relationships of N-terminal pro-B-natriuretic peptide and cardiac troponin T to left ventricular mass and function and mortality in asymptomatic hemodialysis patients.无症状血液透析患者中N末端前B型利钠肽原和心肌肌钙蛋白T与左心室质量、功能及死亡率的关系
Am J Kidney Dis. 2007 Dec;50(6):1009-19. doi: 10.1053/j.ajkd.2007.08.017.
7
Home blood pressures are of greater prognostic value than hemodialysis unit recordings.家庭血压比血液透析单位记录具有更大的预后价值。
Clin J Am Soc Nephrol. 2007 Nov;2(6):1228-34. doi: 10.2215/CJN.02250507. Epub 2007 Oct 17.
8
Activated vitamin D attenuates left ventricular abnormalities induced by dietary sodium in Dahl salt-sensitive animals.活性维生素D可减轻膳食钠在 Dahl 盐敏感型动物中诱发的左心室异常。
Proc Natl Acad Sci U S A. 2007 Oct 23;104(43):16810-5. doi: 10.1073/pnas.0611202104. Epub 2007 Oct 17.
9
Pre- and postdialysis blood pressures are imprecise estimates of interdialytic ambulatory blood pressure.透析前和透析后的血压是对透析间期动态血压的不准确估计。
Clin J Am Soc Nephrol. 2006 May;1(3):389-98. doi: 10.2215/CJN.01891105. Epub 2006 Apr 12.
10
The epidemiology of systolic blood pressure and death risk in hemodialysis patients.血液透析患者收缩压与死亡风险的流行病学研究
Am J Kidney Dis. 2006 Oct;48(4):606-15. doi: 10.1053/j.ajkd.2006.07.005.

透析间动态高血压的流行病学和容量过多的作用。

Epidemiology of interdialytic ambulatory hypertension and the role of volume excess.

机构信息

Indiana University School of Medicine and Richard L. Roudebush Veterans Administration Medical Center, 1481 West 10th Street, Indianapolis, IN 46202, USA.

出版信息

Am J Nephrol. 2011;34(4):381-90. doi: 10.1159/000331067. Epub 2011 Sep 2.

DOI:10.1159/000331067
PMID:21893975
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3182044/
Abstract

BACKGROUND

The epidemiology of hypertension among hemodialysis (HD) patients is difficult to describe accurately because of difficulties in the assessment of blood pressure (BP).

METHODS

Using 44-hour interdialytic ambulatory BP measurements, we describe the epidemiology of hypertension in a cohort of 369 patients. To seek correlates of hypertension control, antihypertensive agents were withdrawn among patients with controlled hypertension and ambulatory BP monitoring was repeated.

RESULTS

Hypertension (defined as an average ambulatory systolic BP ≥135 mm Hg or diastolic BP ≥85 mm Hg, or the use of antihypertensive medications) was prevalent in 82% of the patients and independently associated with epoetin use, lower body mass index and fewer years on dialysis. Although 89% of the patients were being treated, hypertension was controlled adequately in only 38%. Poor control was independently associated with greater antihypertensive drug use. Inferior vena cava (IVC) diameter in expiration was associated with increased risk of poorly controlled hypertension both in cross-sectional analysis and after withdrawal of antihypertensive drugs.

CONCLUSIONS

Interdialytic hypertension is highly prevalent and difficult to control among HD patients. End-expiration IVC diameter is associated with poor control of hypertension in cross-sectional analyses as well as after washout of antihypertensive drugs. Among HD patients, an attractive target for improving hypertension control appears to be the reduction of extracellular fluid volume.

摘要

背景

由于血压评估困难,血液透析 (HD) 患者的高血压流行病学情况很难准确描述。

方法

我们使用 44 小时的透析间动态血压测量,描述了 369 例患者队列中高血压的流行病学情况。为了寻找高血压控制的相关因素,我们在血压控制良好的患者中停用降压药物并重复进行动态血压监测。

结果

高血压(定义为平均动态收缩压≥135mmHg 或舒张压≥85mmHg,或使用降压药物)在 82%的患者中普遍存在,并与促红细胞生成素的使用、较低的体重指数和较少的透析年限独立相关。尽管 89%的患者正在接受治疗,但仅有 38%的患者血压得到了充分控制。控制不佳与降压药物的使用量更大独立相关。下腔静脉(IVC)直径在呼气时与高血压控制不佳的风险增加相关,这在横断面分析和降压药物洗脱后都是如此。

结论

血液透析患者的透析间高血压非常普遍且难以控制。下腔静脉直径在呼气末与高血压控制不佳在横断面分析以及降压药物洗脱后均相关。在血液透析患者中,减少细胞外液量似乎是改善高血压控制的一个有吸引力的目标。